Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiao Zhan

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Chemical Science|March 27, 2023
Modulating the electronic structure of atomically dispersed Fe-Pt dual-site catalysts for efficient oxygen reduction reactionsWei-Shen Song, Mei Wang, Xiao Zhan, et al.
Angewandte Chemie (International Ed. in English)|February 9, 2025
Three-Dimensional Metal-Organic Frameworks with Selectively Activated Aromatic Rings for High-Capacity and High-Rate Lithium-Ion StorageSha Li, Jiande Lin, Huiqun Wang, et al.
Food & Function|July 6, 2022
Dietary intake of one-carbon metabolism-related nutrients and hepatocellular carcinoma survival in the Guangdong Liver Cancer CohortTong-Tong He, Hong-Wei Xiao, Maierhaba Wusiman, et al.
Biomaterials Science|May 5, 2021
Nano-enabled coordination platform of bismuth nitrate and cisplatin prodrug potentiates cancer chemoradiotherapy <i>via</i> DNA damage enhancementYin-Chu Ma, Xin-Feng Tang, You-Cui Xu, et al.
Gut|February 17, 2022
PD-L1 blockade liberates intrinsic antitumourigenic properties of glycolytic macrophages in hepatocellular carcinomaLi-Gong Lu, Zhi-Ling Zhou, Xu-Yan Wang, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 13, 2014
Sorafenib continuation after first disease progression could reduce disease flares and provide survival benefits in patients with hepatocellular carcinoma: a pilot retrospective studySi-Rui Fu, Ying-Qiang Zhang, Yong Li, et al.
Natural Product Communications|December 15, 2018
Metabolites from Penicillium sp. Associated with Paris polyphyllaLi Xiao-Zhan, Ruan Bao-Hui, Yang Ya-Bin, et al.
Food & Function|October 28, 2021
Dietary protein and prognosis of hepatocellular carcinoma: a prospective cohort studyDinuerguli Yishake, Tong-Tong He, Zhao-Yan Liu, et al.
Artificial Cells, Nanomedicine, and Biotechnology|January 22, 2019
Activation of MET promotes resistance to sorafenib in hepatocellular carcinoma cells via the AKT/ERK1/2-EGR1 pathwayQing-Feng Xiang, Mei-Xiao Zhan, Yong Li, et al.
Medical Oncology (Northwood, London, England)|September 4, 2014
The relationship of kinase insert domain receptor gene polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients treated with sorafenibYou-Bing Zheng, Mei-Xiao Zhan, Wei Zhao, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Chemical Science|March 27, 2023
Modulating the electronic structure of atomically dispersed Fe-Pt dual-site catalysts for efficient oxygen reduction reactionsWei-Shen Song, Mei Wang, Xiao Zhan, et al.
Angewandte Chemie (International Ed. in English)|February 9, 2025
Three-Dimensional Metal-Organic Frameworks with Selectively Activated Aromatic Rings for High-Capacity and High-Rate Lithium-Ion StorageSha Li, Jiande Lin, Huiqun Wang, et al.
Food & Function|July 6, 2022
Dietary intake of one-carbon metabolism-related nutrients and hepatocellular carcinoma survival in the Guangdong Liver Cancer CohortTong-Tong He, Hong-Wei Xiao, Maierhaba Wusiman, et al.
Biomaterials Science|May 5, 2021
Nano-enabled coordination platform of bismuth nitrate and cisplatin prodrug potentiates cancer chemoradiotherapy <i>via</i> DNA damage enhancementYin-Chu Ma, Xin-Feng Tang, You-Cui Xu, et al.
Gut|February 17, 2022
PD-L1 blockade liberates intrinsic antitumourigenic properties of glycolytic macrophages in hepatocellular carcinomaLi-Gong Lu, Zhi-Ling Zhou, Xu-Yan Wang, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 13, 2014
Sorafenib continuation after first disease progression could reduce disease flares and provide survival benefits in patients with hepatocellular carcinoma: a pilot retrospective studySi-Rui Fu, Ying-Qiang Zhang, Yong Li, et al.
Natural Product Communications|December 15, 2018
Metabolites from Penicillium sp. Associated with Paris polyphyllaLi Xiao-Zhan, Ruan Bao-Hui, Yang Ya-Bin, et al.
Food & Function|October 28, 2021
Dietary protein and prognosis of hepatocellular carcinoma: a prospective cohort studyDinuerguli Yishake, Tong-Tong He, Zhao-Yan Liu, et al.
Artificial Cells, Nanomedicine, and Biotechnology|January 22, 2019
Activation of MET promotes resistance to sorafenib in hepatocellular carcinoma cells via the AKT/ERK1/2-EGR1 pathwayQing-Feng Xiang, Mei-Xiao Zhan, Yong Li, et al.
Medical Oncology (Northwood, London, England)|September 4, 2014
The relationship of kinase insert domain receptor gene polymorphisms and clinical outcome in advanced hepatocellular carcinoma patients treated with sorafenibYou-Bing Zheng, Mei-Xiao Zhan, Wei Zhao, et al.
Pageof 6